Results 21 to 30 of about 673,470 (204)

Meningococcal vaccine evolution

Clinical Management Issues, 2012
Neisseria meningitidis is a leading cause of bacterial sepsis and meningitis worldwide. Although polysaccharide and glycoconjugate vaccines have been developed for serogroups A, C, Y and W-135, currently there are no broadly effective vaccines available ...
Gianni Bona, Carla Guidi
doaj   +5 more sources

Meningococcal vaccination in pregnancy [PDF]

Human Vaccines & Immunotherapeutics, 2018
Invasive meningococcal disease causes meningitis and septicemia worldwide with highest rates of disease occurring in children
Bahaa Abu Raya, Manish Sadarangani
doaj   +3 more sources

The important lessons lurking in the history of meningococcal epidemiology

Expert Review of Vaccines
Introduction The epidemiology of invasive meningococcal disease (IMD), a rare but potentially fatal illness, is typically described as unpredictable and subject to sporadic outbreaks.Areas covered Meningococcal epidemiology and vaccine use during the ...
Ray Borrow, Jamie Findlow
doaj   +2 more sources

Meningococcal Vaccines

Tuberculin Skin Test in Children, 2017
Manolya Kara, Ayper Somer
semanticscholar   +5 more sources

The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection

Expert Review of Vaccines, 2017
Introduction: The 2015 Global Meningococcal Initiative (GMI) meeting discussed the global importance of meningococcal disease (MD) and its continually changing epidemiology.
Ray Borrow, Dominique A Caugant, Hannah Christensen   +2 more
exaly   +2 more sources

Impact of meningococcal group B OMV vaccines, beyond their brief

Human Vaccines & Immunotherapeutics, 2018
Meningococcal group B outer membrane vesicle vaccines have been used widely in Cuba, New Zealand, and Brazil. They are immunogenic and initially assessed largely by their ability to induce serum bactericidal activity.
Helen Petousis-Harris
doaj   +2 more sources

Global epidemiology of serogroup B meningococcal disease and opportunities for prevention with novel recombinant protein vaccines

Human Vaccines and Immunotherapeutics, 2018
Rodolfo Villena, Marco Aurélio Palazzi Safadi, Maria TERESA Valenzuela   +2 more
exaly   +2 more sources

Current status and challenges of meningococcal vaccines development in China

Zhongguo gonggong weisheng, 2022
Vaccination is the most effective and economical way to prevent meningococcal meningitis. In the past few decades, with widespread use of meningococcal vaccines, the incidence of meningococcal meningitis has dropped significantly. There are some vaccines
Ying-hua XU, Ya-nan LI, Qiang YE
doaj   +1 more source

World Experience in the Use Serogroup B Meningococcal Vaccines (literature review)

Эпидемиология и вакцинопрофилактика, 2022
Relevance. The success of vaccine prophylaxis of meningococcal infection depends on the composition and properties of vaccine preparations and the strict implementation of recommendations on vaccine prophylaxis tactics by the territorial epidemiological ...
I. S. Koroleva, M. A. Koroleva
doaj   +1 more source

Meningococcal Vaccinations [PDF]

Infectious Diseases and Therapy, 2016
Neisseria meningitidis, a gram-negative diplococcal bacterium, is a common asymptomatic nasopharyngeal colonizer that may infrequently lead to invasive disease in the form of meningitis or bacteremia. Six serogroups (A, B, C, W, X and Y) are responsible for the majority of invasive infections.
Crum-Cianflone, Nancy, Sullivan, Eva
openaire   +2 more sources